{"transactions":[{"id":943,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-09-02T21:03:34.000Z","date":"2026-09-01","kind":"gift","planned":false,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee."}],"balance_after":193646,"source":{"system":"sec-edgar","filing":"0001628280-26-060179","document":"wk-form4_1788383011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026060179/wk-form4_1788383011.xml","form_type":"4"}},{"id":676183,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-08-25T20:41:33.000Z","date":"2026-08-21","kind":"gift","planned":false,"acquired":false,"shares":152426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee."}],"balance_after":273646,"source":{"system":"sec-edgar","filing":"0001628280-26-058918","document":"wk-form4_1787690491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026058918/wk-form4_1787690491.xml","form_type":"4"}},{"id":858588,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":38195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":76389,"derivative":{"underlying":"Class A Common Stock","underlying_shares":38195},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858587,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":397554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":397554},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858586,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":24258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":72774,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858585,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":49694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":49695,"derivative":{"underlying":"Class A Common Stock","underlying_shares":49694},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858584,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":39252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39252},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858583,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":19136,"price":13.3,"value":254508.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":426072,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858582,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":38195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":445208,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858581,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":199175,"price":13.31,"value":2651019.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":407013,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858580,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":397554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":606188,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858579,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12154,"price":13.31,"value":161769.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":208634,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858578,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":24258,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":220788,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858577,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24897,"price":13.31,"value":331379.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":196530,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858576,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":49694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":221427,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858575,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":19945,"price":13.31,"value":265467.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":171733,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858574,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":39252,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":191678,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":867525,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-03T21:26:36.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":65359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 65,359 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents a performance-based restricted stock unit grant of 65,359 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":65359,"derivative":{"underlying":"Class A Common Stock","underlying_shares":65359},"source":{"system":"sec-edgar","filing":"0001628280-26-013878","document":"wk-form4_1772573190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013878/wk-form4_1772573190.xml","form_type":"4"}},{"id":867524,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T21:26:36.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":65359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 2, 2027."}],"balance_after":65359,"derivative":{"underlying":"Class A Common Stock","underlying_shares":65359},"source":{"system":"sec-edgar","filing":"0001628280-26-013878","document":"wk-form4_1772573190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026013878/wk-form4_1772573190.xml","form_type":"4"}},{"id":1057877,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Stock Option","published_at":"2025-08-22T20:38:07.000Z","date":"2025-08-20","kind":"exercise","planned":false,"acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options are fully vested."}],"balance_after":97480,"derivative":{"exercise_price":2.75,"underlying":"Class A Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001628280-25-041033","document":"wk-form4_1755895080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025041033/wk-form4_1755895080.xml","form_type":"4"}},{"id":1057876,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-22T20:38:07.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":279244,"price":9.38,"value":2619308.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.40 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":152426,"source":{"system":"sec-edgar","filing":"0001628280-25-041033","document":"wk-form4_1755895080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025041033/wk-form4_1755895080.xml","form_type":"4"}},{"id":1057875,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-22T20:38:07.000Z","date":"2025-08-20","kind":"exercise","planned":false,"acquired":true,"shares":175000,"price":2.75,"value":481250.0,"ownership":{"direct":true},"balance_after":431670,"source":{"system":"sec-edgar","filing":"0001628280-25-041033","document":"wk-form4_1755895080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025041033/wk-form4_1755895080.xml","form_type":"4"}},{"id":1067821,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:38:14.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":33436,"price":9.05,"value":302595.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.07 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":256670,"source":{"system":"sec-edgar","filing":"0001723128-25-000048","document":"wk-form4_1755117489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312825000048/wk-form4_1755117489.xml","form_type":"4"}},{"id":1217479,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:18:31.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":125000,"price":8.89,"value":1111250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.70 to $9.00 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote."}],"balance_after":290106,"source":{"system":"sec-edgar","filing":"0001628280-25-011310","document":"wk-form4_1741382302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025011310/wk-form4_1741382302.xml","form_type":"4"}},{"id":1222606,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":38194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 4, 2024, the Reporting Person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 4, 2024, the Reporting Person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":114582,"derivative":{"underlying":"Class A Common Stock","underlying_shares":38194},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222605,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":97032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2026."}],"balance_after":97033,"derivative":{"underlying":"Class A Common Stock","underlying_shares":97032},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222604,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":194064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 97,032 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in\nthe table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 97,032 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in\nthe table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period."}],"balance_after":194064,"derivative":{"underlying":"Class A Common Stock","underlying_shares":194064},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222603,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":157005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted\nperformance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These\nunits were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted\nperformance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These\nunits were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted\nperformance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These\nunits were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":157005},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222602,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":49694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":99389,"derivative":{"underlying":"Class A Common Stock","underlying_shares":49694},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222601,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":39251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":39252,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39251},"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222600,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":19537,"price":8.84,"value":172707.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":415106,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222599,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":38194,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":434643,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222598,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":80309,"price":8.76,"value":703506.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":396449,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222597,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":157005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted\nperformance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These\nunits were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5."}],"balance_after":476758,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222596,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":25419,"price":8.76,"value":222670.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":319753,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222595,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":49694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":345172,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222594,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":20077,"price":8.76,"value":175874.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":295478,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1222593,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-06T01:18:50.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":39251,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":315555,"source":{"system":"sec-edgar","filing":"0001628280-25-010718","document":"wk-form4_1741223923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010718/wk-form4_1741223923.xml","form_type":"4"}},{"id":1228783,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2025-03-05T00:03:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":31371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31371},"source":{"system":"sec-edgar","filing":"0001628280-25-010118","document":"wk-form4_1741133025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010118/wk-form4_1741133025.xml","form_type":"4"}},{"id":1228782,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-05T00:03:52.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11737,"price":8.67,"value":101759.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":276304,"source":{"system":"sec-edgar","filing":"0001628280-25-010118","document":"wk-form4_1741133025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010118/wk-form4_1741133025.xml","form_type":"4"}},{"id":1228781,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2025-03-05T00:03:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":31371,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":288041,"source":{"system":"sec-edgar","filing":"0001628280-25-010118","document":"wk-form4_1741133025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025010118/wk-form4_1741133025.xml","form_type":"4"}},{"id":1431399,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-08-16T20:18:22.000Z","date":"2024-08-15","kind":"sale","planned":false,"acquired":false,"shares":40225,"price":7.85,"value":315766.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price included in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.92 per share, inclusive.  The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":256670,"source":{"system":"sec-edgar","filing":"0001628280-24-037559","document":"wk-form4_1723839496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024037559/wk-form4_1723839496.xml","form_type":"4"}},{"id":1431398,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-08-16T20:18:22.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":22486,"price":7.81,"value":175615.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.84 per share, inclusive.  The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":296895,"source":{"system":"sec-edgar","filing":"0001628280-24-037559","document":"wk-form4_1723839496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024037559/wk-form4_1723839496.xml","form_type":"4"}},{"id":1596637,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":305556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 152,778 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period.  The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents a performance-based restricted stock unit grant of 152,778 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period.  The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period."}],"balance_after":305556,"derivative":{"underlying":"Class A Common Stock","underlying_shares":305556},"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596636,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":152778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest in four equal annual installments beginning on March 4, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest in four equal annual installments beginning on March 4, 2025."}],"balance_after":152778,"derivative":{"underlying":"Class A Common Stock","underlying_shares":152778},"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596635,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":49694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":149083,"derivative":{"underlying":"Class A Common Stock","underlying_shares":49694},"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596634,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":39251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":78503,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39251},"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596633,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":31371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":31371,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31371},"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596632,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24897,"price":5.47,"value":136186.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":319381,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596631,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":49694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":344278,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596630,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":19665,"price":5.47,"value":107567.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":294584,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596629,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":39251,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":314249,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596628,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":16219,"price":5.47,"value":88717.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":274998,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1596627,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-03-05T21:40:49.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":31371,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":291217,"source":{"system":"sec-edgar","filing":"0001628280-24-008951","document":"wk-form4_1709674816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024008951/wk-form4_1709674816.xml","form_type":"4"}},{"id":1610092,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T21:26:56.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":31663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31663},"source":{"system":"sec-edgar","filing":"0001628280-24-007998","document":"wk-form4_1709241999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007998/wk-form4_1709241999.xml","form_type":"4"}},{"id":1610091,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-02-29T21:26:56.000Z","date":"2024-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":16556,"price":5.71,"value":94534.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":259846,"source":{"system":"sec-edgar","filing":"0001628280-24-007998","document":"wk-form4_1709241999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007998/wk-form4_1709241999.xml","form_type":"4"}},{"id":1610090,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2024-02-29T21:26:56.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":31663,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":276402,"source":{"system":"sec-edgar","filing":"0001628280-24-007998","document":"wk-form4_1709241999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024007998/wk-form4_1709241999.xml","form_type":"4"}},{"id":1807392,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-08-15T20:30:13.000Z","date":"2023-08-11","kind":"sale","planned":false,"acquired":false,"shares":29302,"price":4.1267,"value":120920.5634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.22, inclusive. The reporting person undertakes to provide to Amneal Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":244739,"source":{"system":"sec-edgar","filing":"0001209191-23-045846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123045846/doc4.xml","form_type":"4"}},{"id":1836383,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:30:16.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":23095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":23095},"source":{"system":"sec-edgar","filing":"0001209191-23-041087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123041087/doc4.xml","form_type":"4"}},{"id":1836382,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-07-05T20:30:16.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":11571,"price":3.1,"value":35870.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Class A Common Stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":274041,"source":{"system":"sec-edgar","filing":"0001209191-23-041087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123041087/doc4.xml","form_type":"4"}},{"id":1836381,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-07-05T20:30:16.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":23095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of Class A Common Stock, par value $0.01 per share (the \"Class A Common Stock\") issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":285612,"source":{"system":"sec-edgar","filing":"0001209191-23-041087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123041087/doc4.xml","form_type":"4"}},{"id":1966084,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-03-07T23:00:35.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":397554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents a performance-based restricted stock unit grant of 198,777 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 198,777 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents a performance-based restricted stock unit grant of 198,777 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Represents a performance-based restricted stock unit grant of 198,777 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Represents a performance-based restricted stock unit grant of 198,777 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2026, the last day of the performance period."}],"balance_after":397554,"derivative":{"underlying":"Class A Common Stock","underlying_shares":397554},"source":{"system":"sec-edgar","filing":"0001209191-23-016929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016929/doc4.xml","form_type":"4"}},{"id":1966083,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T23:00:35.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":198777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2024."}],"balance_after":198777,"derivative":{"underlying":"Class A Common Stock","underlying_shares":198777},"source":{"system":"sec-edgar","filing":"0001209191-23-016929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016929/doc4.xml","form_type":"4"}},{"id":1966082,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T23:00:35.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":39251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 3, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":117754,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39251},"source":{"system":"sec-edgar","filing":"0001209191-23-016929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016929/doc4.xml","form_type":"4"}},{"id":1966081,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:00:35.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":19685,"price":1.92,"value":37795.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":262517,"source":{"system":"sec-edgar","filing":"0001209191-23-016929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016929/doc4.xml","form_type":"4"}},{"id":1966080,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-07T23:00:35.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":39251,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":282202,"source":{"system":"sec-edgar","filing":"0001209191-23-016929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123016929/doc4.xml","form_type":"4"}},{"id":1973934,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":31371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":62742,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31371},"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1973933,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":12346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 49,383 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 49,383 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12346},"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1973932,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":16121,"price":2.09,"value":33692.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":242951,"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1973931,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":31371,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":259072,"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1973930,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":6846,"price":2.09,"value":14308.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":227701,"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1973929,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-03T21:31:10.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":12346,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":234547,"source":{"system":"sec-edgar","filing":"0001209191-23-015521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123015521/doc4.xml","form_type":"4"}},{"id":1983838,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:30:57.000Z","date":"2023-02-27","kind":"exercise","acquired":false,"shares":31662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":31663,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31662},"source":{"system":"sec-edgar","filing":"0001209191-23-014118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014118/doc4.xml","form_type":"4"}},{"id":1983837,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-01T21:30:57.000Z","date":"2023-02-27","kind":"tax_withholding","acquired":false,"shares":17557,"price":2.16,"value":37923.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":222201,"source":{"system":"sec-edgar","filing":"0001209191-23-014118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014118/doc4.xml","form_type":"4"}},{"id":1983836,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2023-03-01T21:30:57.000Z","date":"2023-02-27","kind":"exercise","acquired":true,"shares":31662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":239758,"source":{"system":"sec-edgar","filing":"0001209191-23-014118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123014118/doc4.xml","form_type":"4"}},{"id":2214812,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-07-05T20:15:34.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":23094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."}],"balance_after":23095,"derivative":{"underlying":"Class A Common Stock","underlying_shares":23094},"source":{"system":"sec-edgar","filing":"0001209191-22-040624","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122040624/doc4.xml","form_type":"4"}},{"id":2214811,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-07-05T20:15:34.000Z","date":"2022-06-30","kind":"tax_withholding","acquired":false,"shares":11582,"price":3.18,"value":36830.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":208096,"source":{"system":"sec-edgar","filing":"0001209191-22-040624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122040624/doc4.xml","form_type":"4"}},{"id":2214810,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-07-05T20:15:34.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":23094,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":219678,"source":{"system":"sec-edgar","filing":"0001209191-22-040624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122040624/doc4.xml","form_type":"4"}},{"id":2276241,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:41:14.000Z","date":"2022-05-07","kind":"exercise","acquired":false,"shares":16656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 66,622 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 66,622 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16656},"source":{"system":"sec-edgar","filing":"0001209191-22-028154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028154/doc4.xml","form_type":"4"}},{"id":2276240,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:41:14.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":8353,"price":3.4,"value":28400.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":196584,"source":{"system":"sec-edgar","filing":"0001209191-22-028154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028154/doc4.xml","form_type":"4"}},{"id":2276239,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:41:14.000Z","date":"2022-05-07","kind":"exercise","acquired":true,"shares":16656,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":204937,"source":{"system":"sec-edgar","filing":"0001209191-22-028154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028154/doc4.xml","form_type":"4"}},{"id":2354815,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":314010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 157,005 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 157,005 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 157,005 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 157,005 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Represents a performance-based restricted stock unit grant of 157,005 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."}],"balance_after":314010,"derivative":{"underlying":"Class A Common Stock","underlying_shares":314010},"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354814,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":157005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."}],"balance_after":157005,"derivative":{"underlying":"Class A Common Stock","underlying_shares":157005},"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354813,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":31370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":94113,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31370},"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354812,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":12346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 49,383 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 49,383 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":12346,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12346},"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354811,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":15733,"price":4.45,"value":70011.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":188281,"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354810,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":31370,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":204014,"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354809,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":6192,"price":4.45,"value":27554.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":172644,"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2354808,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:17:27.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":12346,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":178836,"source":{"system":"sec-edgar","filing":"0001209191-22-016047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016047/doc4.xml","form_type":"4"}},{"id":2365569,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T22:08:52.000Z","date":"2022-02-27","kind":"exercise","acquired":false,"shares":31662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":63325,"derivative":{"underlying":"Class A Common Stock","underlying_shares":31662},"source":{"system":"sec-edgar","filing":"0001209191-22-014133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014133/doc4.xml","form_type":"4"}},{"id":2365568,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:08:52.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":16434,"price":4.59,"value":75432.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":166490,"source":{"system":"sec-edgar","filing":"0001209191-22-014133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014133/doc4.xml","form_type":"4"}},{"id":2365567,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:08:52.000Z","date":"2022-02-27","kind":"exercise","acquired":true,"shares":31662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":182924,"source":{"system":"sec-edgar","filing":"0001209191-22-014133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014133/doc4.xml","form_type":"4"}},{"id":2647798,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-07-01T20:03:44.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":23095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 1, 2021, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 1, 2021, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021."}],"balance_after":46189,"derivative":{"underlying":"Class A Common Stock","underlying_shares":23095},"source":{"system":"sec-edgar","filing":"0001209191-21-044367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121044367/doc4.xml","form_type":"4"}},{"id":2647797,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-07-01T20:03:44.000Z","date":"2021-06-30","kind":"tax_withholding","acquired":false,"shares":11583,"price":5.12,"value":59304.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":151262,"source":{"system":"sec-edgar","filing":"0001209191-21-044367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121044367/doc4.xml","form_type":"4"}},{"id":2647796,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-07-01T20:03:44.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":23095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":162845,"source":{"system":"sec-edgar","filing":"0001209191-21-044367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121044367/doc4.xml","form_type":"4"}},{"id":2718724,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:54:20.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":16655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 66,622 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 66,622 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":16656,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16655},"source":{"system":"sec-edgar","filing":"0001209191-21-031565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031565/doc4.xml","form_type":"4"}},{"id":2718723,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:54:20.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":8353,"price":5.2,"value":43435.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":139750,"source":{"system":"sec-edgar","filing":"0001209191-21-031565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031565/doc4.xml","form_type":"4"}},{"id":2718722,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:54:20.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":16655,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":148103,"source":{"system":"sec-edgar","filing":"0001209191-21-031565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031565/doc4.xml","form_type":"4"}},{"id":2814131,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-03-03T22:02:09.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":250966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."}],"balance_after":250966,"derivative":{"underlying":"Class A Common Stock","underlying_shares":250966},"source":{"system":"sec-edgar","filing":"0001209191-21-016976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016976/doc4.xml","form_type":"4"}},{"id":2814130,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:02:09.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":125483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."}],"balance_after":125483,"derivative":{"underlying":"Class A Common Stock","underlying_shares":125483},"source":{"system":"sec-edgar","filing":"0001209191-21-016976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016976/doc4.xml","form_type":"4"}}],"next_cursor":"2021-03-03T22:02:09.000000Z,2814130"}